http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115128272-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38de0df856f3856facdf027dbc7f8c66 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67c38ecf6439cbde84835946c2832639 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00dbddac2700384d3cb1bc9ea899f9e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22bb54a89ae0ab91f52ecd75bfe3224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d6ac230d10c627846653fb1c69794f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df8596158a247a3e7fc78e86de15ad66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d80c01364920328f4fa29c19adb9e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb68147d87264277d36c8b21a519e08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43853e0aa92196936f6e14a6fd5f2aba |
| publicationDate | 2022-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115128272-A |
| titleOfInvention | A combination of biomarkers related to lung cancer, kit containing same and use thereof |
| abstract | The invention discloses a combination of biomarkers related to lung cancer, a kit containing the same, and uses thereof. The biomarker combination comprises ESO-1, TM4SF1, p53, BMI1, FXR1 and EFHD2 antigens or autoantibodies bound thereto, and the kit includes reagents for detecting the biomarkers in the biomarker combination. The invention also discloses a non-diagnostic detection method using the biomarker combination or kit, a lung cancer diagnosis system, a computer-readable medium capable of realizing the function of the lung cancer diagnosis system, and a lung cancer diagnosis device. The biomarker combination of the present invention has higher sensitivity and specificity, and more types of tumor autoantibodies are combined for detection, thereby greatly improving the detection accuracy. The kit of the invention has reasonable design, feasible technology, stable and reliable quality control system, good product stability, simple operation, reliable and accurate detection results, and high clinical application value. |
| priorityDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.